Sign in
Taking peopleNo phase

Extra oxygen treatment in a pressure chamber after leg or foot amputation

Tests hyperbaric oxygen therapy after lower limb amputation in adults with diabetes or poor circulation.

Key facts

Who runs it
Oslo University Hospital
Where
Norway2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Additional Hyperbaric Oxygen After Lower Extremity Amputation
Status
Recruiting
People taking part
120 people, planned
Started
4 Jul 2018
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Hyperbaric oxygen therapy
Record updated
30 March 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have had a leg or foot amputation because of a long-lasting wound, bone infection (osteomyelitis), poor blood flow or dead tissue. They will get either hyperbaric oxygen therapy (breathing pure oxygen in a pressure chamber) or standard care.

Age
18 Years to 90 Years
Sex
All sexes can join.
Disease stage
Lower leg or foot amputation because of a chronic wound, osteomyelitis, ischemia (poor blood flow) or necrosis (dead tissue). People must join within 7 days after their final surgery.
Earlier treatment
Must have had a lower extremity amputation. An anesthesiologist or hyperbaric medicine doctor must find them fit to receive hyperbaric oxygen therapy.

Main reasons for not taking part

  • Pregnancy
  • Dementia
  • Not able to cooperate and attend follow-up appointments

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Lower extremity amputation because of chronic wound, osteomyelitis, ischemia, necrosis
  • Fit to receive hyperbaric oxygen therapy determined by an anesthesiologist/Hyperbaric Medicine Physician
  • Able to cooperate and follow up appointments
  • Included within 7 days after final surgery

Who cannot take part

  • Dementia
  • Not fulfilling inclusion criteria
  • Pregnancy

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.

The 2 groups in the trial

  • Hyperbaric oxygen therapyTreatment being tested

    30 sessions of Hyperbaric oxygen therapy, 90min treatment at 2,4 ATA(atmosphere absolute) with 100% oxygen.First session must be given within 7 days after initial amputation. Treatment is given as outpatient treatment after discharge from hospital.

  • Control groupNo study treatment, for comparison

    Control group will be given standard of care with follow up at the outpatient clinic after discharge from hospital.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Additional Hyperbaric Oxygen After Lower Extremity Amputation - A Randomized Controlled Trial
Plain-language title
Extra oxygen treatment in a pressure chamber after leg or foot amputationGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT03594344, who can take part
Record updated
30 March 2025